MannKind Stock Price

-0.125 (-3.72%)
Upgrade to Real-Time
Regular Market
Volume 3,386,656
Bid Price 3.23
Ask Price 3.24
News -
Day High 3.37


52 Week Range


Day Low 3.21
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
MannKind Corporation MNKD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.125 -3.72% 3.235 13:29:30
Open Price Low Price High Price Close Price Prev Close
3.345 3.21 3.37 3.36
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,392 3,386,656 $ 3.28 $ 11,116,503 - 2.49 - 5.53
Last Trade Time Type Quantity Stock Price Currency
13:29:37 42 $ 3.24 USD


Draw Mode:

MannKind Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 817.05M 252.57M 246.96M $ 75.44M $ -63.38M -0.32 -8.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 267.67k 3.80%

more financials information »

MannKind News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNKD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.933.372.612.964,544,9130.30510.41%
1 Month3.593.592.613.084,004,357-0.355-9.89%
3 Months3.844.102.493.243,508,336-0.605-15.76%
6 Months4.804.882.493.633,021,522-1.57-32.6%
1 Year4.275.532.494.083,022,908-1.04-24.24%
3 Years1.276.250.803.023,109,8311.97154.72%
5 Years1.146.960.802.833,352,5872.10183.77%

MannKind Description

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.